Psyence Biomedical Ltd.
PBM
$0.5168
-$0.0165-3.09%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.93M | 733.20K | 733.20K | 733.20K | 605.10K |
| Total Receivables | 125.10K | -- | 41.70K | 41.70K | 18.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 156.20K | -- | 322.10K | 322.10K | 15.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.60K | -- | 29.60K | 29.60K | 29.60K |
| Total Current Assets | 2.24M | -- | 1.13M | 1.13M | 669.00K |
|
|
|||||
| Total Current Assets | 2.24M | -- | 1.13M | 1.13M | 669.00K |
| Net Property, Plant & Equipment | 10.10K | -- | 5.50K | 5.50K | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.25M | -- | 1.13M | 1.13M | 669.00K |
|
|
|||||
| Total Accounts Payable | 805.60K | -- | 562.40K | 562.40K | 914.50K |
| Total Accrued Expenses | 12.00K | -- | 126.00K | 126.00K | -- |
| Short-term Debt | 1.30M | -- | 10.45M | 10.45M | 736.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.39M | -- | 968.50K | 968.50K | -- |
| Total Other Current Liabilities | 1.39M | -- | 968.50K | 968.50K | -- |
| Total Current Liabilities | 3.51M | -- | 12.10M | 12.10M | 1.65M |
|
|
|||||
| Total Current Liabilities | 3.51M | -- | 12.10M | 12.10M | 1.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.30M | -- | 10.45M | 10.45M | 736.60K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.51M | -- | 12.10M | 12.10M | 1.65M |
|
|
|||||
| Common Stock & APIC | 52.94M | -- | 46.13M | 46.13M | -982.10K |
| Retained Earnings | -54.50M | -- | -57.46M | -57.46M | -- |
| Treasury Stock & Other | 302.50K | -- | 361.10K | 361.10K | -- |
| Total Common Equity | -1.26M | -10.97M | -10.97M | -10.97M | -982.10K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.26M | -10.97M | -10.97M | -10.97M | -982.10K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.26M | -10.97M | -10.97M | -10.97M | -982.10K |
|
|
|||||